The greater atherogenicity of nonpurified diets versus semipurified diets in hamsters is mediated via differences in plasma lipoprotein cholesterol distribution, ldl oxidative susceptibility, and plasma α-tocopherol concentration

Journal of Nutritional Biochemistry

Volumn 9, Issue 10, 1998, Pages 591-597

  Nicolosi, Robert J ^a   Wilson, Thomas A ^a   Lawton, Carl ^b   Rogers, Eugene J ^a   Wiseman, Sheila A ^c   Tijburg, Lilian B M ^c   Kritchevsky, David ^d  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b University of Massachusetts   (United States)

^c UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^d WISTAR INSTITUTE   (United States)

Author keywords

Antioxidants; Atherosclerosis; Cholesterol; Hamsters; Lipoprotein oxidation

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; DIET; FAT INTAKE; HAMSTER; HYPERCHOLESTEROLEMIA; LIPID OXIDATION; MALE; NONHUMAN; OXIDATION;

EID: 0032190492     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(98)00054-0     Document Type: Article

References (47)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol Modifications of low-density lipoprotein that increase its atherogenicity . N. Engl. J. Med. 320:1989;915-924.
2. Rosenfeld M.E., Palinski W., Yla-Herttuala S., Witztum J.L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:1989;336-349.
3. Palinski W., Rosenfeld M.E., Yla-Herttuala S., Gurther G.C., Socher S.W., et al. Low density lipoprotein undergoes oxidative modifications in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
4. Salonen J.T., Yla-Herttuala S., Yamamoto R., Butler S., Korpela H., et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
5. Esterbauer H., Puhl H., Dieber-Rotheneder M., Waeg G. Effect of antioxidants on oxidative modification of LDL. Ann. Med. 23:1991;573-581.
6. Abbey M., Nestel P.J., Baghurst P.A. Antioxidant vitamins and low-density lipoprotein oxidation. Am. J. Clin. Nutr. 58:1993;525-532.
7. Dieber-Rotheneder M., Puhl H., Waeg G., Striegl G., Esterbauer H. Effect of oral supplementation with d-alpha tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid Res. 32:1991;1325-1332.
8. Reaven P.D., Khouw A., Beltz W.F., Parthasarathy S., Witzum J.L. Effect of dietary antioxidant combinations in humans Protection of LDL by vitamin E but not by β-carotene . Arterioscler. Thromb. 13:1993;590-600.
9. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., Bostick R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med. 334:1996;1156-1162.
10. Rimm E.B., Stampfer M.J., Ascherio A., Giavannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1993;1450-1456.
11. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1993;1444-1449.
12. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheesman K., et al. Randomized controlled trial of vitamin E in patients with coronary disease Cambridge Heart Antioxidant Study (CHAOS) . Lancet. 347:1966;781-787.
13. Lynch S.M., Frei B. Antioxidants as antiatherogens animal studies . Frei B. Natural Antioxidants in Human Health and Disease. 1994;353-385 Academic Press, San Diego, CA, USA.
14. Dam H. Ineffectiveness of vitamin E in preventing cholesterol deposition in the aorta. J. Nutr. 28:1944;289-295.
15. 12, and pancreatic extracts to influence plasma lipids and atherogenesis in cholesterol-fed chicks. Circulation. 8:1954;455-456.
16. Brattsand R. Actions of vitamins A and E and some nicotinic acid derivatives on plasma lipids and lipid infiltration of aortas in cholesterol-fed rabbits. Atherosclerosis. 22:1975;47-61.
17. Sulkin N.M., Sulkin D.F. Intimal lesions in arteries of vitamin E-deficient rats. Proc. Soc. Exp. Biol. Med. 103:1960;111-115.
18. Wilson R.B., Middleton C.C., Sun G.Y. Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits. J. Nutr. 108:1978;1858-1867.
19. Morel D.W., de la Llera-Moya M., Friday K.E. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. J. Nutr. 124:1994;2123-2130.
20. Willingham A.K., Bolanos C., Bohannan E., Cenedella R.J. The effects of high levels of vitamin E on the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. J. Nutr. Biochem. 4:1993;651-654.
21. Kleinveld H.A., Hak-Lemmers H.L.M., Hectors M.P.C., de Fouw N.J., Demacker P.N.M., Stalenhoef A.F.H. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15:1995;290-297.
22. Parker R.A., Sabrah T., Cap M., Gill B.T. Relation of vascular oxidative stress, α-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler. Thromb. Vasc. Biol. 15:1995;349-358.
23. Verlangieri A.J., Bush M.J. Effects of d-α-tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 11:1992;131-138.
24. Stein O., Dabach Y., Hollander G., Halperin G., Thiery J., Stein Y. Relative resistance of the hamster to aortic atherosclerosis in spite of prolonged vitamin E deficiency and dietary hypercholesterolemia Putative effect of increased HDL? Biochim Biophys Acta. 1299:1996;216-222.
25. Parthasarathy S., Khoo J.C., Miller E., Barnett J., Witztum J.L., Steinberg D. Low-density lipoprotein rich in oleic acid is protected against oxidative modification Implications for dietary prevention of atherosclerosis . Proc. Natl. Acad. Sci. USA. 87:1990;3894-3898.
26. Terpstra A.H.M., Holmes J.C., Nicolosi R.J. The hypocholesterolemic effect of dietary soy protein vs. casein in hamsters fed cholesterol-free or cholesterol-enriched semi-purified diets. J. Nutr. 121:1991;944-947.
27. Krause B.R., Bousley R.F., Kieft K.A., Stanfield R.L. Effect of the ACAT inhibitor CI-976 on plasma cholesterol concentrations and distribution in hamsters fed zero- and no-cholesterol diets. Clin. Biochem. 25:1992;371-377.
28. Daley S.J., Herderick E.E., Cornhill J.F., Rogers K.A. Cholesterol-fed and casein-fed rabbit models of atherosclerosis Part 1. Differing lesion area and volume despite equal plasma cholesterol levels . Arterioscler. Thromb. 14:1994;95-104.
29. Daley S.J., Klemp K.F., Guyton J.R., Rogers K.A. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 2. Differing morphological severity of atherogenesis despite matched plasma cholesterol levels. Arterioscler Thromb. 14:1994;105-114.
30. Kowala M.C., Nunnari J.J., Durham S.K., Nicolosi R.J. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters. Atherosclerosis. 91:1991;35-49.
31. Rogers E.J., Rice S.M., Nicolosi R.J., Carpenter D.R., McClelland C.A., Romanczyk L.J. Jr. Identification and quantitation of γ-oryzanol components and simultaneous assessment of tocols in rice bran oil. JAOCS. 70:1993;301-307.
32. Kaplan L.A., Stein E.A., Willett W.C., Stampfer M.J., Stryker W.S. Reference ranges for retinol, tocopherols, lycopene and alpha- and beta-carotene in plasma by simultaneous high-performance liquid chromatographic analysis. Clin. Physiol. Biochem. 5:1987;297-304.
33. Terpstra A.H.M., Holmes J.C., Nicolosi R.J. The hypocholesterolemic effect of dietary soybean protein vs. casein in hamsters fed cholesterol free or cholesterol-enriched semipurified diets. J. Nutr. 121:1991;944-947.
34. Markwell M.A.K., Haas S.M., Bieber L.L., Tolberb N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:1978;206-210.
35. Frei B., Gaziano J.M. Content of antioxidants, preformed lipid hydroperoxides and cholesterol as predictors of the susceptibility of human LDL to metal ion dependent and independent oxidation. J. Lipid Res. 34:1993;2135-2145.
36. Esterbauer H., Striegl G., Puhl H., Totheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6:1989;67-75.
37. Foxall T.L., Shwaery G.T., Stucchi A.F., Nicolosi R.J., Wong S.S. Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model. Am. J. Pathol. 140:1992;1357-1363.
38. Snedecor G.W., Cochran W. Statistical Methods. 1980;The Iowa State University Press, Ames, IA USA.
39. Salonen J.T., Nyyssonen K., Korpela H., Tuomilehto J., Seppanen R. High stores of iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 86:1992;803-811.
40. McClain C., Morris P., Hennig B. Zinc and endothelial function. J. Nutr. 11:(suppl):1995;117-120.
41. Ripa S., Ripa R. Zinc and atherosclerosis. Minerva Med. 12:1994;647-654.
42. Kritchevsky D., Tepper S.A., Czarnecki S.K., Klurfield D.M. Atherogenecity of animal and vegetable protein Influence of the lysine/arginine ratio . Atherosclerosis. 41:1982;429-431.
43. Shaish A., Daugherty A., O'Sullivan F., Schonfeld G., Heinecke J.W. Beta-carotene inhibits atherosclerosis in hypercholesteroleamic rabbits. J. Clin. Invest. 93:1994;844-851.
44. LaRosa J.C. Cholesterol and cardiovascular disease How strong is the evidence . Clin. Cardiol. 15:1992;2-7.
45. Rubin E.M., Krauss R.M., Spangler E.A., Verstuyft J.G., Clift S.M. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-1. Nature (Lond). 353:1991;265-267.
46. Plump A.S., Scott C., Breslow J.L. Human apolipoprotein A-1 gene expression raises HDL and suppresses atherosclerosis in apo E deficient mice. Proc. Natl. Acad. Sci. USA. 91:1995;9607-9611.
47. Paszty C.N., Maeda N., Verstuft J., Rubin E.M. Apolipoprotein A-1 transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94:1994;899-903.